Mycobacterium tuberculosis antigen-specific T cell

The term **Mycobacterium tuberculosis antigen-specific T cell** refers not to a single gene, protein, or molecular target, but to a population of T lymphocytes (CD4+ and CD8+) that specifically recognize and respond to antigens derived from *Mycobacterium tuberculosis*, the causative agent of tuberculosis. These T cells play a central role in immune protection and pathogenesis during both acute and chronic infection by recognizing MHC-presented *M. tuberculosis* peptides and mounting responses characterized by cytokine secretion, proliferation, and in some cases cytotoxicity. Their functions include producing interferon-gamma (IFN-γ), tumor necrosis factor (TNF), and interleukin-2 (IL-2), critical for activating macrophages and coordinating the immune response to control bacterial replication[2][3][4][5]. The quantity and quality of these antigen-specific T cells (e.g., “polyfunctional” versus single-cytokine producers) correlate with different stages of infection, disease activity, and treatment response[4][5]. Analysis of their frequency and function forms the basis of immunological diagnostics for tuberculosis, such as the interferon-gamma release assay (IGRA), and they are of research interest for vaccine development and as biomarkers of disease risk or efficacy[1][5]. **This is not a conventional therapeutic target such as a receptor, enzyme, or transporter, but rather a heterogeneous immune cell population defined by specificity for a pathogen.** The label is therefore incorrect as a molecular drug target, but the characterization of these T cells is of immunological and diagnostic relevance[1][2][4][5][7].

Other names

M. tuberculosis antigen-specific T cellMtb-specific T cellMycobacterium tuberculosis-specific T cell